SCHEMBL16487121

SCHEMBL16487121

Nc1ncnc2c1ncn2Sc1ccc(Cl)cc1Cl

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ PI4KA P42356 7/20 0.51
▸ PI4K2B Q8TCG2 7/20 0.51
▸ PI4K2A Q9BTU6 7/20 0.51
▸ PI4KB Q9UBF8 7/20 0.51
▸ HSP90B1 P14625 9/20 0.49
▸ TRAP1 Q12931 3/20 0.49
▸ HSP90AA1 P07900 2/20 0.45
▸ HSP90AB1 P08238 1/20 0.45
▸ NSD2 O96028 1/20 0.44
▸ NSD3 Q9BZ95 1/20 0.44
▸ ADORA2A P29274 4/20 0.42
▸ ADORA1 P30542 3/20 0.42
▸ GSK3B P49841 1/20 0.41
▸ EGFR P00533 1/20 0.40
▸ P2RX7 Q99572 1/20 0.40
▸ ADORA2B P29275 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5039983 0.73 PI4KA (0.56) PI4KAPI4K2BPI4K2API4KBADORA2A
SCHEMBL28459777 0.70 HSP90B1 (0.62) HSP90B1TRAP1HSP90AA1HSP90AB1
SCHEMBL258584 0.70 ADORA2A (0.59) PI4KAPI4K2BPI4K2API4KBADORA2A
SCHEMBL28455587 0.69 HSP90B1 (0.77) HSP90B1TRAP1HSP90AA1HSP90AB1
SCHEMBL16487455 0.69 HSP90B1 (0.76) HSP90B1TRAP1HSP90AA1HSP90AB1
SCHEMBL14920226 0.68 PI4KA (0.62) PI4KAPI4K2BPI4K2API4KBNSD2
SCHEMBL27774840 0.67 PI4KA (0.44) PI4KAPI4K2BPI4K2API4KBADORA2A
SCHEMBL16486551 0.67 HSP90AA1 (0.51) HSP90B1TRAP1HSP90AA1HSP90AB1
SCHEMBL16486667 0.66 HSP90B1 (1.00) HSP90B1TRAP1HSP90AA1HSP90AB1
SCHEMBL17900181 0.66 HSP90B1 (0.74) HSP90B1TRAP1HSP90AA1HSP90AB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3033338-A2 SELECTIVE GRP94 INHIBITORS AND USES THEREOF Memorial Sloan-Kettering Cancer Center (US) 2016-06-22 — — EP disclosed
WO-2015023976-A2 SELECTIVE GRP94 INHIBITORS AND USES THEREOF MEMORIAL SLOAN-KETTERING CANCER CENTER (US) 2015-02-19 — — WO disclosed
Send feedback